The University of Chicago Header Logo

Search Result Details

This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following properties of Blair, John Edward A.
PropertyValue
keywords heart failure with preserved ejection fraction
overview John Blair, MD, FACC, is a cardiologist who specializes in the care of complex coronary artery disease, mitral and aortic valve disease and congestive heart failure. Dr. Blair performs a wide range of procedures for the diagnosis and treatment of coronary artery disease, including radial artery catheterization, balloon angioplasty, coronary stent placement, rotational orbital and excimer laser atherectomy, and treatment of chronic total occlusions (CTOs). Dr. Blair is also a member of the structural heart team, and treats mitral and aortic valve disease. He is one of the primary operators for the transcatheter mitral valve repair (MitraClip) procedures, and has extensive experience in transcatheter aortic valve replacement (TAVR). He is one of few cardiologists who perform coronary physiology studies, which aid in diagnosing coronary microvascular dysfunction in a range of challenging clinical scenarios. His research interests focus on coronary microvascular dysfunction in patients with various cardiovascular conditions, including heart failure with preserved ejection fraction (HFpEF) and CTOs. Prior to joining the University of Chicago Medicine, Dr. Blair was a Major in the United States Air Force Medical Corps, where he served as staff cardiologist at the San Antonio Military Medical Center and Wilford Hall Medical Center in San Antonio, Texas.
One or more keywords matched the following items that are connected to Blair, John Edward A.
Item TypeName
Concept Heart Failure
Academic Article Comparison of hand-carried ultrasound assessment of the inferior vena cava and N-terminal pro-brain natriuretic peptide for predicting readmission after hospitalization for acute decompensated heart failure.
Academic Article Usefulness of hand-carried ultrasound to predict elevated left ventricular filling pressure.
Academic Article Use of hand carried ultrasound, B-type natriuretic peptide, and clinical assessment in identifying abnormal left ventricular filling pressures in patients referred for right heart catheterization.
Academic Article Left Ventricular Assist Device Deactivation via Percutaneous Closure of the Outflow Graft.
Academic Article Heart Failure With Preserved Ejection Fraction: Have We Finally Found the Perfect Noninvasive Biomarker?
Academic Article Microvascular dysfunction and cardiac fibrosis in heart failure with preserved ejection fraction: a case report.
Academic Article Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.
Academic Article Efficacy of oral tolvaptan in acute heart failure patients with hypotension and renal impairment.
Academic Article Rationale and design of the hemodynamic, echocardiographic and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure (HORIZON-HF) trial.
Academic Article Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial.
Academic Article The effects of eplerenone on length of stay and total days of heart failure hospitalization after myocardial infarction in patients with left ventricular systolic dysfunction.
Academic Article Weight changes after hospitalization for worsening heart failure and subsequent re-hospitalization and mortality in the EVEREST trial.
Academic Article Istaroxime, a first in class new chemical entity exhibiting SERCA-2 activation and Na-K-ATPase inhibition: a new promising treatment for acute heart failure syndromes?
Academic Article Continental differences in clinical characteristics, management, and outcomes in patients hospitalized with worsening heart failure results from the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) program.
Academic Article Mechanical circulatory support devices for acute heart failure syndromes: considerations for clinical trial design.
Academic Article Hemodynamic, echocardiographic, and neurohormonal effects of istaroxime, a novel intravenous inotropic and lusitropic agent: a randomized controlled trial in patients hospitalized with heart failure.
Academic Article Prognostic markers in heart failure--congestion, neurohormones, and the cardiorenal syndrome.
Academic Article Heart failure in North America.
Academic Article Causes of death and rehospitalization in patients hospitalized with worsening heart failure and reduced left ventricular ejection fraction: results from Efficacy of Vasopressin Antagonism in Heart Failure Outcome Study with Tolvaptan (EVEREST) program.
Academic Article Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure association of the European Society of Cardiology and endorsed by the European Society of Intensive Care Medicine.
Academic Article Effects of istaroxime on diastolic stiffness in acute heart failure syndromes: results from the Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: a Randomized Controlled Trial in Patients Hospitalized with Heart Failure (HORIZON-HF) trial.
Academic Article Coronary Microvascular Dysfunction and Clinical Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.
Academic Article Aortic pulsatility index predicts clinical outcomes in heart failure: a sub-analysis of the ESCAPE trial.
Academic Article Aortic Pulsatility Index: A Novel Hemodynamic Variable for Evaluation of Decompensated Heart Failure.
Academic Article Left Ventricular Pressure Ratio Predicts In-Hospital Outcomes in Hospitalized Heart Failure With Reduced Ejection Fraction.
Academic Article A composite metric for predicting benefit from spironolactone in heart failure with preserved ejection fraction.
Search Criteria
  • Heart Failure